Aditxt Inc. (ADTX)
Market Open
8 Dec, 19:58
NASDAQ (CM) NASDAQ (CM) Primary $
3. 31
+0.23
+7.63%
$
67.56K Market Cap
- P/E Ratio
0% Div Yield
829,160 Volume
-42.18 Eps
$ 3.08
Previous Close Day Range
2.65 3.34
Year Range
2.36 10,311.25
Want to track ADTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biotech News: Why Is Aditxt (ADTX) Stock Up 49% Today?
Aditxt (NASDAQ: ADTX ) stock is rising higher on Wednesday after the company notified investors of an update on a clinical trial conducted by its subsidiary Pearsanta. According to a press release from Aditxt, Pearsanta has submitted a Clinical Trial Translational Endpoints Research Award proposal to the Congressionally Directed Medical Research Programs (CDMRP) of the Department of Defense.
Investorplace | 1 year ago
Why Is Aditxt (ADTX) Stock Up 72% Today!
Aditxt (NASDAQ: ADTX ) stock is up on Wednesday after the biotech company announced an amended and restated merger agreement with Evofem Biosciences (OTCMKTS: EVFM ). Aditxt notes that the merger agreement was amended and restated as Evofem Biosciences has some critical needs ahead of it.
Investorplace | 1 year ago
2025 © Marketlog. All Rights Reserved.
